Evidence map›Paper›PMID 41535585›Full record

ReviewArchives of toxicology2026

Chikungunya: global epidemiology, clinical spectrum, and vector control-lessons for China from the 2025 Guangdong outbreak.

Yaoyao Dai, Zhenyu Li, Xinyu Zhang, Qihong Gu, Jingsheng Xu, Minjie Chu

Abstract readReview
PubMed Publisher
In one paragraph

Review in Archives of toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yaoyao Dai *Department of Epidemiology, Institute for Applied Research in Public Health, Key Laboratory of Jiangsu Higher Education Institutions for Advanced Medical Analytics and Public Health, School of Public Health, Nantong University, Nantong, China.
Zhenyu Li *Department of Epidemiology, Institute for Applied Research in Public Health, Key Laboratory of Jiangsu Higher Education Institutions for Advanced Medical Analytics and Public Health, School of Public Health, Nantong University, Nantong, China.
Xinyu ZhangDepartment of Epidemiology, Institute for Applied Research in Public Health, Key Laboratory of Jiangsu Higher Education Institutions for Advanced Medical Analytics and Public Health, School of Public Health, Nantong University, Nantong, China.
Qihong GuDepartment of Epidemiology, Institute for Applied Research in Public Health, Key Laboratory of Jiangsu Higher Education Institutions for Advanced Medical Analytics and Public Health, School of Public Health, Nantong University, Nantong, China.
Jingsheng XuDepartment of Epidemiology, Institute for Applied Research in Public Health, Key Laboratory of Jiangsu Higher Education Institutions for Advanced Medical Analytics and Public Health, School of Public Health, Nantong University, Nantong, China.
Minjie ChuDepartment of Epidemiology, Institute for Applied Research in Public Health, Key Laboratory of Jiangsu Higher Education Institutions for Advanced Medical Analytics and Public Health, School of Public Health, Nantong University, Nantong, China. chuminjie@ntu.edu.cn.ORCID 0000-0002-7533-9119

Funding

the National Key Research and Development Program of China 2022YFC2503202the National Natural Science Foundation of China 82273715
6 · The paper itself

Abstract

Chikungunya virus (CHIKV) is a re-emerging mosquito-borne virus that has spread from Africa to Asia and the Americas, posing a growing global threat to public health. In China, following the first imported case in 2008 and subsequent local outbreaks, the largest nationwide epidemic occurred in 2025 with nearly 9,000 confirmed cases. Clinically, CHIKV infection is characterized by high fever, rash, and severe arthralgia, often leading to long-term joint pain and reduced quality of life. The virus is primarily transmitted by Aedes albopictus and Aedes aegypti, with transmission dynamics influenced by climate variability, rainfall patterns, and human mobility. As no licensed vaccine or specific antiviral therapy is currently available, this review summarizes recent advances in CHIKV epidemiology, pathogenesis, and prevention, emphasizing its potential public health threat and offering scientific insights to guide future surveillance and control efforts.

Indexed as

Chikungunya FeverChikungunya virusAedesAnimalsChinaDisease OutbreaksHumansMosquito ControlMosquito VectorsChikungunya virusClimate changeClinical manifestationsEpidemiologyInfectious disease

Identifiers

PMID41535585

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.